drug · small molecule
grapiprant
Phase 2updated 3mo agoby AskAt Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 4 investigational indications.
targets
Prostaglandin E2 receptor EP4 subtype
all catalysts(0)
nothing on the calendar yet
Trials studying grapiprant
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that